PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Experimental Medicine, University of Tor Vergata, Rome, Italy; Lifebrain srl, Viale Roma 190/A, Guidonia Montecelio, Rome, Italy; Department of Clinical Biochemistry, Tor Vergata University Hospital, Rome, Italy. Electronic address: massimo.pieri@uniroma2.it.\', \'Virology Unit, Tor Vergata University Hospital, Rome, Italy.\', \'Lifebrain srl, Viale Roma 190/A, Guidonia Montecelio, Rome, Italy.\', \'Department of Experimental Medicine, University of Tor Vergata, Rome, Italy; Department of Clinical Biochemistry, Tor Vergata University Hospital, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0009-8981(20)30465-410.1016/j.cca.2020.09.033
?:hasPublicationType
?:journal
  • Clinica chimica acta; international journal of clinical chemistry
is ?:pmid of
?:pmid
?:pmid
  • 33002475
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • SARS-CoV-2 infection serology validation of different methods: Usefulness of IgA in the early phase of infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all